We are live on
!
Find out more
FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$3.89B
1-Year Est. Return
201.1%
This Fund
S&P 500
This Quarter
Est. Return
+29.57%
1 Year Est. Return
+201.1%
3 Year Est. Return
+879.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$310M
(+24%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
7.72%
Top 10 Holdings %
Top 10 Hldgs %
66.37%
Holding
50
New
7
Increased
9
Reduced
5
Closed
6
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
+$92.8M |
| 2 |
IMGO
Imago BioSciences, Inc. Common stock
IMGO
|
+$25.4M |
| 3 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
+$10.7M |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$9.54M |
| 5 |
KALV
KalVista Pharmaceuticals
KALV
|
+$8.93M |
Top Sells
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$26.7M |
| 2 |
FLACU
Frazier Lifesciences Acquisition Corporation Unit
FLACU
|
+$15.2M |
| 3 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$9.31M |
| 4 |
Vaxcyte
PCVX
|
+$5.89M |
| 5 |
MacroGenics
MGNX
|
+$2.43M |
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLVX
1
DELISTED
HilleVax
HLVX
| $163M | 10.15% |
9,758,359
| – | – |
|
|
IMGO
2
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $143M | 8.91% |
3,987,207
+1,015,933
| +34% | +$25.4M |
|
3
Arcutis Biotherapeutics
ARQT
$3.46B
| $129M | 7.99% |
8,684,232
| – | – |
|
|
KDNY
4
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $114M | 7.08% |
4,345,559
+80,000
| +2% | +$1.77M |
|
|
5
NewAmsterdam Pharma
NAMS
$3.7B
| $102M | 6.33% |
+9,341,551
| New | +$92.8M |
|
6
Syndax Pharmaceuticals
SNDX
$2.04B
| $94.4M | 5.87% |
3,708,838
+296,000
| +9% | +$6.9M |
|
7
Phathom Pharmaceuticals
PHAT
$878M
| $94.3M | 5.86% |
8,407,152
| – | – |
|
8
Krystal Biotech
KRYS
$10.2B
| $79.2M | 4.92% |
999,737
-18,651
| -2% | -$1.38M |
|
9
Mirum Pharmaceuticals
MIRM
$7.19B
| $75.3M | 4.68% |
3,860,107
+32,326
| +0.8% | +$639K |
|
|
VRNA
10
DELISTED
Verona Pharma
VRNA
| $73.6M | 4.57% |
2,815,720
+716,179
| +34% | +$9.54M |
|
|
11
Vaxcyte
PCVX
$7.99B
| $67M | 4.17% |
1,397,405
-150,000
| -10% | -$5.89M |
|
12
Rhythm Pharmaceuticals
RYTM
$7.28B
| $55.2M | 3.43% |
1,894,000
| – | – |
|
|
ALLK
13
DELISTED
Allakos
ALLK
| $40.3M | 2.51% |
4,792,000
| – | – |
|
14
AnaptysBio
ANAB
$1.6B
| $27.9M | 1.73% |
899,700
| – | – |
|
15
Tarsus Pharmaceuticals
TARS
$2.57B
| $26.2M | 1.63% |
1,787,527
| – | – |
|
16
Crinetics Pharmaceuticals
CRNX
$8.88B
| $25.9M | 1.61% |
1,414,823
| – | – |
|
17
Replimune Group
REPL
$756M
| $25.3M | 1.58% |
931,560
+125,293
| +16% | +$2.6M |
|
18
Cogent Biosciences
COGT
$6.49B
| $24.4M | 1.52% |
2,109,154
+35,000
| +2% | +$434K |
|
|
ALPN
19
DELISTED
Alpine Immune Sciences Inc
ALPN
| $21.9M | 1.36% |
2,985,757
| – | – |
|
|
KALV
20
DELISTED
KalVista Pharmaceuticals
KALV
| $21.9M | 1.36% |
3,238,859
+1,666,667
| +106% | +$8.93M |
|
|
GRTS
21
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $17.8M | 1.11% |
5,162,348
-75,000
| -1% | -$214K |
|
22
Sutro Biopharma
STRO
$403M
| $14.4M | 0.89% |
177,648
| – | – |
|
23
Acadia Pharmaceuticals
ACAD
$4.42B
| $13.6M | 0.85% |
857,338
| – | – |
|
|
SLN
24
Silence Therapeutics
SLN
$490M
| $13.4M | 0.84% |
881,173
| – | – |
|
25
Trevi Therapeutics
TRVI
$2.46B
| $12.9M | 0.8% |
6,663,590
+1,260,000
| +23% | +$2.48M |
|
Similar funds
GAMH
MSI
CCM
TFM
SCM
MIM
AA
DACG